The impact of multidisciplinary team decision-making in locally advanced and recurrent rectal cancer
Authors:
- 1 September 2022
- journal article
- research article
- Published by Royal College of Surgeons of England in The Annals of The Royal College of Surgeons of England
- Vol. 104 (8) , 611-617
Abstract
Introduction: Appropriate patient selection within the context of a multidisciplinary team (MDT) is key to good clinical outcomes. The current evidence base for factors that guide the decision-making process in locally advanced rectal cancer (LARC) and locally recurrent rectal cancer (LRRC) is limited to anatomical factors. Methods: A registry-based, prospective cohort study was undertaken of patients referred to our specialist MDT between 2015 and 2019. Data were collected on patients and disease characteristics including performance status, Charlson Comorbidity Index, the English Index of Multiple Deprivation quintiles and MDT treatment decision. Curative treatment was defined as neoadjuvant treatment and surgical resection that would achieve a R0 resection, and/or complete treatment of distant metastatic disease. Palliative treatment was defined as non-surgical treatment. Results: In total, 325 patients were identified; 72.7% of patients with LARC and 63.6% of patients with LRRC were offered treatment with curative intent (p = 0.08). Patients with poor performance status (PS > 2; p < 0.001), severe comorbidity (p < 0.001), socio-economic deprivation (p = 0.004), a positive predictive circumferential resection margin (p = 0.005) and metastatic disease (p < 0.001) were associated with palliative treatment. Overall survival in the curative cohort was 49 months (95% confidence interval [CI] 32.4–65.5) compared with 12 months (95% CI 9.1–14.9) in the palliative cohort (p < 0.001). The presence of metastatic disease was identified as a prognostic factor for patients undergoing curative treatment (p = 0.05). The only prognostic factor identified in patients treated palliatively was performance status (p < 0.001). Conclusions: Our study identifies a number of preoperative, prognostic factors that affect MDT decision-making and overall survival.Keywords
This publication has 34 references indexed in Scilit:
- Consensus statement on the multidisciplinary management of patients with recurrent and primary rectal cancer beyond total mesorectal excision planesBritish Journal of Surgery, 2013
- Surgery for recurrent rectal cancer: higher and wider?Colorectal Disease, 2013
- Current UK management of locally recurrent rectal cancerColorectal Disease, 2012
- Meta‐analysis of survival based on resection margin status following surgery for recurrent rectal cancerColorectal Disease, 2012
- Improving patient survival with the colorectal cancer multi‐disciplinary teamColorectal Disease, 2009
- Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational studyBMJ, 2006
- Imaging for Predicting the Risk Factors—the Circumferential Resection Margin and Nodal Disease—of Local Recurrence in Rectal Cancer: A Meta-AnalysisSeminars in Ultrasound, CT and MRI, 2005
- Surgery for Locally Recurrent Rectal CancerDiseases of the Colon & Rectum, 2005
- Colorectal Cancer Pelvic Recurrences: Determinants of ResectabilityDiseases of the Colon & Rectum, 2004
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987